3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;3-cyclopentyl-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-2,4-dimethyl-N-(2H-tetrazol-5-ylmethyl)furan-3-carboxamide;N-(1-hydroxyindazol-5-yl)-3-methyl-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)cyclopropanecarboxamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide

C124H117BrFN57O17 — CID 162009000

IUPAC3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;3-cyclopentyl-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-2,4-dimethyl-N-(2H-tetrazol-5-ylmethyl)furan-3-carboxamide;N-(1-hydroxyindazol-5-yl)-3-methyl-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)cyclopropanecarboxamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide
SMILESCCC(=O)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1.Cc1cccc(C(=O)N(Cc2nn[nH]n2)c2ccc3c(cnn3O)c2)c1.Cc1coc(C)c1C(=O)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1.O=C(C1CC1)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1.O=C(CCC1CCCC1)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1.O=C(CCc1ccccc1)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1.O=C(c1cc(F)cc(Br)c1)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1.O=C(c1cccnc1)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1
InChIInChI=1S/C18H17N7O2.C17H15N7O2.C17H21N7O2.C16H11BrFN7O2.C16H15N7O3.C15H12N8O2.C13H13N7O2.C12H13N7O2/c26-18(9-6-13-4-2-1-3-5-13)24(12-17-20-22-23-21-17)15-7-8-16-14(10-15)11-19-25(16)27;1-11-3-2-4-12(7-11)17(25)23(10-16-19-21-22-20-16)14-5-6-15-13(8-14)9-18-24(15)26;25-17(8-5-12-3-1-2-4-12)23(11-16-19-21-22-20-16)14-6-7-15-13(9-14)10-18-24(15)26;17-11-3-9(4-12(18)6-11)16(26)24(8-15-20-22-23-21-15)13-1-2-14-10(5-13)7-19-25(14)27;1-9-8-26-10(2)15(9)16(24)22(7-14-18-20-21-19-14)12-3-4-13-11(5-12)6-17-23(13)25;24-15(10-2-1-5-16-7-10)22(9-14-18-20-21-19-14)12-3-4-13-11(6-12)8-17-23(13)25;21-13(8-1-2-8)19(7-12-15-17-18-16-12)10-3-4-11-9(5-10)6-14-20(11)22;1-2-12(20)18(7-11-14-16-17-15-11)9-3-4-10-8(5-9)6-13-19(10)21/h1-5,7-8,10-11,27H,6,9,12H2,(H,20,21,22,23);2-9,26H,10H2,1H3,(H,19,20,21,22);6-7,9-10,12,26H,1-5,8,11H2,(H,19,20,21,22);1-7,27H,8H2,(H,20,21,22,23);3-6,8,25H,7H2,1-2H3,(H,18,19,20,21);1-8,25H,9H2,(H,18,19,20,21);3-6,8,22H,1-2,7H2,(H,15,16,17,18);3-6,21H,2,7H2,1H3,(H,14,15,16,17)
InChIKeyYTFHECDZYLMUFV-UHFFFAOYSA-N
MW2776.58 g/mol
LogP13.05
Rot. Bonds36

About 3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;3-cyclopentyl-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-2,4-dimethyl-N-(2H-tetrazol-5-ylmethyl)furan-3-carboxamide;N-(1-hydroxyindazol-5-yl)-3-methyl-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)cyclopropanecarboxamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide

3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;3-cyclopentyl-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-2,4-dimethyl-N-(2H-tetrazol-5-ylmethyl)furan-3-carboxamide;N-(1-hydroxyindazol-5-yl)-3-methyl-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)cyclopropanecarboxamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide (PubChem CID 162009000) has the molecular formula C124H117BrFN57O17 and a molecular weight of 2776.58 g/mol. Its IUPAC name is 3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;3-cyclopentyl-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-2,4-dimethyl-N-(2H-tetrazol-5-ylmethyl)furan-3-carboxamide;N-(1-hydroxyindazol-5-yl)-3-methyl-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)cyclopropanecarboxamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide.

Molecular Properties

Compound Name3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;3-cyclopentyl-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-2,4-dimethyl-N-(2H-tetrazol-5-ylmethyl)furan-3-carboxamide;N-(1-hydroxyindazol-5-yl)-3-methyl-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)cyclopropanecarboxamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide
PubChem CID162009000
Molecular FormulaC124H117BrFN57O17
Molecular Weight2776.58 g/mol
Exact Mass2773.92
IUPAC Name3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;3-cyclopentyl-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-2,4-dimethyl-N-(2H-tetrazol-5-ylmethyl)furan-3-carboxamide;N-(1-hydroxyindazol-5-yl)-3-methyl-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)cyclopropanecarboxamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide
SMILESCCC(=O)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1.Cc1cccc(C(=O)N(Cc2nn[nH]n2)c2ccc3c(cnn3O)c2)c1.Cc1coc(C)c1C(=O)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1.O=C(C1CC1)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1.O=C(CCC1CCCC1)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1.O=C(CCc1ccccc1)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1.O=C(c1cc(F)cc(Br)c1)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1.O=C(c1cccnc1)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1
InChIInChI=1S/C18H17N7O2.C17H15N7O2.C17H21N7O2.C16H11BrFN7O2.C16H15N7O3.C15H12N8O2.C13H13N7O2.C12H13N7O2/c26-18(9-6-13-4-2-1-3-5-13)24(12-17-20-22-23-21-17)15-7-8-16-14(10-15)11-19-25(16)27;1-11-3-2-4-12(7-11)17(25)23(10-16-19-21-22-20-16)14-5-6-15-13(8-14)9-18-24(15)26;25-17(8-5-12-3-1-2-4-12)23(11-16-19-21-22-20-16)14-6-7-15-13(9-14)10-18-24(15)26;17-11-3-9(4-12(18)6-11)16(26)24(8-15-20-22-23-21-15)13-1-2-14-10(5-13)7-19-25(14)27;1-9-8-26-10(2)15(9)16(24)22(7-14-18-20-21-19-14)12-3-4-13-11(5-12)6-17-23(13)25;24-15(10-2-1-5-16-7-10)22(9-14-18-20-21-19-14)12-3-4-13-11(6-12)8-17-23(13)25;21-13(8-1-2-8)19(7-12-15-17-18-16-12)10-3-4-11-9(5-10)6-14-20(11)22;1-2-12(20)18(7-11-14-16-17-15-11)9-3-4-10-8(5-9)6-13-19(10)21/h1-5,7-8,10-11,27H,6,9,12H2,(H,20,21,22,23);2-9,26H,10H2,1H3,(H,19,20,21,22);6-7,9-10,12,26H,1-5,8,11H2,(H,19,20,21,22);1-7,27H,8H2,(H,20,21,22,23);3-6,8,25H,7H2,1-2H3,(H,18,19,20,21);1-8,25H,9H2,(H,18,19,20,21);3-6,8,22H,1-2,7H2,(H,15,16,17,18);3-6,21H,2,7H2,1H3,(H,14,15,16,17)
InChIKeyYTFHECDZYLMUFV-UHFFFAOYSA-N
XLogP13.05
TPSA928.59 Ų
H-Bond Donors16
H-Bond Acceptors58
Rotatable Bonds36
Heavy Atoms200
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002776.58
LogP ≤ 513.05
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1058

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'N-hydroxyl_pyridine', 'substructure': 'N/A'}

Analyze 3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;3-cyclopentyl-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-2,4-dimethyl-N-(2H-tetrazol-5-ylmethyl)furan-3-carboxamide;N-(1-hydroxyindazol-5-yl)-3-methyl-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)cyclopropanecarboxamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-2,4-dimethyl-N-(2H-tetrazol-5-ylmethyl)furan-3-carboxamide;N-(1-hydroxyindazol-5-yl)-3-methyl-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide;1-hydroxy-N-(3H-1,2,4-triazol-5-ylmethyl)indazol-5-amine;5-[2-(3H-1,2,4-triazol-5-yl)ethyl]-1H-indazole
CID 157726456
3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-2,4-dimethyl-N-(2H-tetrazol-5-ylmethyl)furan-3-carboxamide;N-(1-hydroxyindazol-5-yl)-3-methyl-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide;1-hydroxy-N-(2H-triazol-4-ylmethyl)indazol-5-amine;5-[2-(2H-triazol-4-yl)ethyl]-1H-indazole
CID 159198306
3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;3-chloro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;3-cyclopentyl-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-3,5-dimethyl-N-(2H-tetrazol-5-ylmethyl)-1,2-oxazole-4-carboxamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)cyclopropanecarboxamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide
CID 160172519
3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-2,4-dimethyl-N-(2H-tetrazol-5-ylmethyl)furan-3-carboxamide;N-(1-hydroxyindazol-5-yl)-3-methyl-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide
CID 160390190

Frequently Asked Questions

What is the IUPAC name of 3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;3-cyclopentyl-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-2,4-dimethyl-N-(2H-tetrazol-5-ylmethyl)furan-3-carboxamide;N-(1-hydroxyindazol-5-yl)-3-methyl-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)cyclopropanecarboxamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide?
The IUPAC name of 3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;3-cyclopentyl-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-2,4-dimethyl-N-(2H-tetrazol-5-ylmethyl)furan-3-carboxamide;N-(1-hydroxyindazol-5-yl)-3-methyl-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)cyclopropanecarboxamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide (CID 162009000) is 3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;3-cyclopentyl-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-2,4-dimethyl-N-(2H-tetrazol-5-ylmethyl)furan-3-carboxamide;N-(1-hydroxyindazol-5-yl)-3-methyl-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)cyclopropanecarboxamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide.
What is the SMILES notation for 3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;3-cyclopentyl-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-2,4-dimethyl-N-(2H-tetrazol-5-ylmethyl)furan-3-carboxamide;N-(1-hydroxyindazol-5-yl)-3-methyl-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)cyclopropanecarboxamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide?
The canonical SMILES for 3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;3-cyclopentyl-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-2,4-dimethyl-N-(2H-tetrazol-5-ylmethyl)furan-3-carboxamide;N-(1-hydroxyindazol-5-yl)-3-methyl-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)cyclopropanecarboxamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide is CCC(=O)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1.Cc1cccc(C(=O)N(Cc2nn[nH]n2)c2ccc3c(cnn3O)c2)c1.Cc1coc(C)c1C(=O)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1.O=C(C1CC1)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1.O=C(CCC1CCCC1)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1.O=C(CCc1ccccc1)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1.O=C(c1cc(F)cc(Br)c1)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1.O=C(c1cccnc1)N(Cc1nn[nH]n1)c1ccc2c(cnn2O)c1.
What is the InChIKey of 3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;3-cyclopentyl-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-2,4-dimethyl-N-(2H-tetrazol-5-ylmethyl)furan-3-carboxamide;N-(1-hydroxyindazol-5-yl)-3-methyl-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)cyclopropanecarboxamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide?
The InChIKey is YTFHECDZYLMUFV-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H17N7O2.C17H15N7O2.C17H21N7O2.C16H11BrFN7O2.C16H15N7O3.C15H12N8O2.C13H13N7O2.C12H13N7O2/c26-18(9-6-13-4-2-1-3-5-13)24(12-17-20-22-23-21-17)15-7-8-16-14(10-15)11-19-25(16)27;1-11-3-2-4-12(7-11)17(25)23(10-16-19-21-22-20-16)14-5-6-15-13(8-14)9-18-24(15)26;25-17(8-5-12-3-1-2-4-12)23(11-16-19-21-22-20-16)14-6-7-15-13(9-14)10-18-24(15)26;17-11-3-9(4-12(18)6-11)16(26)24(8-15-20-22-23-21-15)13-1-2-14-10(5-13)7-19-25(14)27;1-9-8-26-10(2)15(9)16(24)22(7-14-18-20-21-19-14)12-3-4-13-11(5-12)6-17-23(13)25;24-15(10-2-1-5-16-7-10)22(9-14-18-20-21-19-14)12-3-4-13-11(6-12)8-17-23(13)25;21-13(8-1-2-8)19(7-12-15-17-18-16-12)10-3-4-11-9(5-10)6-14-20(11)22;1-2-12(20)18(7-11-14-16-17-15-11)9-3-4-10-8(5-9)6-13-19(10)21/h1-5,7-8,10-11,27H,6,9,12H2,(H,20,21,22,23);2-9,26H,10H2,1H3,(H,19,20,21,22);6-7,9-10,12,26H,1-5,8,11H2,(H,19,20,21,22);1-7,27H,8H2,(H,20,21,22,23);3-6,8,25H,7H2,1-2H3,(H,18,19,20,21);1-8,25H,9H2,(H,18,19,20,21);3-6,8,22H,1-2,7H2,(H,15,16,17,18);3-6,21H,2,7H2,1H3,(H,14,15,16,17).
What are the key properties of 3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;3-cyclopentyl-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-2,4-dimethyl-N-(2H-tetrazol-5-ylmethyl)furan-3-carboxamide;N-(1-hydroxyindazol-5-yl)-3-methyl-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)cyclopropanecarboxamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide?
3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;3-cyclopentyl-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-2,4-dimethyl-N-(2H-tetrazol-5-ylmethyl)furan-3-carboxamide;N-(1-hydroxyindazol-5-yl)-3-methyl-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)cyclopropanecarboxamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide has a molecular weight of 2776.58 g/mol, XLogP of 13.05, 36 rotatable bonds, 16 hydrogen bond donors, and 58 hydrogen bond acceptors.
Where does this data come from?
All data for 3-bromo-5-fluoro-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)benzamide;3-cyclopentyl-N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-2,4-dimethyl-N-(2H-tetrazol-5-ylmethyl)furan-3-carboxamide;N-(1-hydroxyindazol-5-yl)-3-methyl-N-(2H-tetrazol-5-ylmethyl)benzamide;N-(1-hydroxyindazol-5-yl)-3-phenyl-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)cyclopropanecarboxamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)propanamide;N-(1-hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide is sourced from PubChem (CID 162009000), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).